Nutraceutical Targeting of Placental Synthesis of Soluble Fms-Like Tyrosine Kinase- 1 (sFlt-1) as Strategy for Preventing and Controlling Pre-eclampsia

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|24|20|2255-2263

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.24, Iss.20, 2018-06, pp. : 2255-2263

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Possible Placental Factor for Preeclampsia: sFlt-1

By  

Current Medicinal Chemistry, Vol. 15, Iss. 7, 2008-03 ,pp. : 711-715

Bentham Science Publishers

Access to resources Recommend Favorite

Soluble fms-like tyrosine kinase-1 antibody for diagnosis purposes (WO2010075475)

By Boyaud France   Inguimbert Nicolas  

Expert Opinion on Therapeutic Patents, Vol. 21, Iss. 6, 2011-06 ,pp. : 971-975

Informa Healthcare

Access to resources Recommend Favorite

FMS-like tyrosine kinase 3 inhibitors: a patent review

By Lee Jongkook   Paek Seung-Mann   Han Sun-Young  

Expert Opinion on Therapeutic Patents, Vol. 21, Iss. 4, 2011-04 ,pp. : 483-503

Informa Healthcare

Access to resources Recommend Favorite

Emerging FMS-like tyrosine kinase 3 inhibitors for the treatment of acute myelogenous leukemia

By Prescott Hillary   Kantarjian Hagop   Cortes Jorge   Ravandi Farhad  

Expert Opinion on Emerging Drugs, Vol. 16, Iss. 3, 2011-09 ,pp. : 407-423

Informa Healthcare

Access to resources Recommend Favorite

Vascular Endothelial Growth Factor (VEGF) and the VEGF Soluble Receptor-1 (sFlt-1) in Chorionic Villus Tissue from Chinese Women with Early Recurrent Spontaneous Abortion

By Pang L-H   Li M-J   Li M-Q   Yang D-M   Shi L  

The Journal of International Medical Research, Vol. 39, Iss. 3, 2011-05 ,pp. : 830-837

Field House Publishing

Access to resources Recommend Favorite